Published in Biol Psychiatry on November 13, 2006
The anatomy of first-episode and chronic schizophrenia: an anatomical likelihood estimation meta-analysis. Am J Psychiatry (2008) 3.29
Differential targeting of the CA1 subfield of the hippocampal formation by schizophrenia and related psychotic disorders. Arch Gen Psychiatry (2009) 2.25
Cognitive control deficits in schizophrenia: mechanisms and meaning. Neuropsychopharmacology (2010) 2.20
Use of neuroanatomical pattern classification to identify subjects in at-risk mental states of psychosis and predict disease transition. Arch Gen Psychiatry (2009) 2.17
A possible role for the striatum in the pathogenesis of the cognitive symptoms of schizophrenia. Neuron (2010) 1.96
Dendritic spine pathology in schizophrenia. Neuroscience (2012) 1.91
Does the salience network play a cardinal role in psychosis? An emerging hypothesis of insular dysfunction. J Psychiatry Neurosci (2012) 1.88
Structural brain alterations in schizophrenia following fetal exposure to the inflammatory cytokine interleukin-8. Schizophr Res (2010) 1.83
Higher levels of glutamate in the associative-striatum of subjects with prodromal symptoms of schizophrenia and patients with first-episode psychosis. Neuropsychopharmacology (2011) 1.78
Is gray matter volume an intermediate phenotype for schizophrenia? A voxel-based morphometry study of patients with schizophrenia and their healthy siblings. Biol Psychiatry (2007) 1.73
White matter integrity and prediction of social and role functioning in subjects at ultra-high risk for psychosis. Biol Psychiatry (2009) 1.65
The role of the insula in schizophrenia. Schizophr Res (2010) 1.52
Brain anatomical abnormalities in high-risk individuals, first-episode, and chronic schizophrenia: an activation likelihood estimation meta-analysis of illness progression. Schizophr Bull (2009) 1.51
Anatomical abnormalities of the anterior cingulate cortex in schizophrenia: bridging the gap between neuroimaging and neuropathology. Schizophr Bull (2008) 1.37
Research in people with psychosis risk syndrome: a review of the current evidence and future directions. J Child Psychol Psychiatry (2010) 1.36
Early recognition and disease prediction in the at-risk mental states for psychosis using neurocognitive pattern classification. Schizophr Bull (2011) 1.36
Progressive changes in the development toward schizophrenia: studies in subjects at increased symptomatic risk. Schizophr Bull (2008) 1.32
Cortical thickness reduction in individuals at ultra-high-risk for psychosis. Schizophr Bull (2009) 1.29
Alterations in white matter evident before the onset of psychosis. Schizophr Bull (2012) 1.29
Gray matter in first-episode schizophrenia before and after antipsychotic drug treatment. Anatomical likelihood estimation meta-analyses with sample size weighting. Schizophr Bull (2009) 1.26
Systemic hypotheses for generalized cognitive deficits in schizophrenia: a new take on an old problem. Schizophr Bull (2008) 1.21
Neuroanatomic predictors to prodromal psychosis in velocardiofacial syndrome (22q11.2 deletion syndrome): a longitudinal study. Biol Psychiatry (2010) 1.12
Neuropsychological profiles in different at-risk states of psychosis: executive control impairment in the early--and additional memory dysfunction in the late--prodromal state. Schizophr Bull (2010) 1.10
Cerebellar networks in individuals at ultra high-risk of psychosis: impact on postural sway and symptom severity. Hum Brain Mapp (2014) 1.06
Altered resting-state connectivity in subjects at ultra-high risk for psychosis: an fMRI study. Behav Brain Funct (2010) 1.06
Inflammatory cytokines and neurological and neurocognitive alterations in the course of schizophrenia. Biol Psychiatry (2013) 1.06
Cortical circuit dysfunction and cognitive deficits in schizophrenia--implications for preemptive interventions. Eur J Neurosci (2012) 1.04
Progressive structural brain changes during development of psychosis. Schizophr Bull (2010) 1.01
Cerebellar-motor dysfunction in schizophrenia and psychosis-risk: the importance of regional cerebellar analysis approaches. Front Psychiatry (2014) 0.99
Hippocampal volume deficits and shape deformities in young biological relatives of schizophrenia probands. Neuroimage (2009) 0.98
5-HT2A receptor density is decreased in the at-risk mental state. Psychopharmacology (Berl) (2007) 0.98
Detecting the psychosis prodrome across high-risk populations using neuroanatomical biomarkers. Schizophr Bull (2014) 0.97
Altered prefrontal and hippocampal function during verbal encoding and recognition in people with prodromal symptoms of psychosis. Schizophr Bull (2009) 0.97
Abnormal relationship between medial temporal lobe and subcortical dopamine function in people with an ultra high risk for psychosis. Schizophr Bull (2011) 0.97
Lack of Evidence for Regional Brain Volume or Cortical Thickness Abnormalities in Youths at Clinical High Risk for Psychosis: Findings From the Longitudinal Youth at Risk Study. Schizophr Bull (2015) 0.93
MRI brain volume abnormalities in young, nonpsychotic relatives of schizophrenia probands are associated with subsequent prodromal symptoms. Schizophr Res (2007) 0.93
Changes in the frontotemporal cortex and cognitive correlates in first-episode psychosis. Biol Psychiatry (2010) 0.92
Functional brain networks before the onset of psychosis: A prospective fMRI study with graph theoretical analysis. Neuroimage Clin (2012) 0.91
Cerebellar Morphology and Procedural Learning Impairment in Neuroleptic-Naive Youth at Ultrahigh Risk of Psychosis. Clin Psychol Sci (2014) 0.90
Structural brain alterations in individuals at ultra-high risk for psychosis: a review of magnetic resonance imaging studies and future directions. J Korean Med Sci (2010) 0.90
Translating the MAM model of psychosis to humans. Trends Neurosci (2014) 0.89
Exploring predictors of outcome in the psychosis prodrome: implications for early identification and intervention. Neuropsychol Rev (2009) 0.89
Neuropsychological testing and structural magnetic resonance imaging as diagnostic biomarkers early in the course of schizophrenia and related psychoses. Neuroinformatics (2011) 0.89
Insular volume abnormalities associated with different transition probabilities to psychosis. Psychol Med (2011) 0.89
Prefrontal function at presentation directly related to clinical outcome in people at ultrahigh risk of psychosis. Schizophr Bull (2009) 0.89
Regional brain atrophy and functional disconnection in Broca's area in individuals at ultra-high risk for psychosis and schizophrenia. PLoS One (2012) 0.88
Mapping cortical morphology in youth with velocardiofacial (22q11.2 deletion) syndrome. J Am Acad Child Adolesc Psychiatry (2011) 0.87
Structural covariance in the hallucinating brain: a voxel-based morphometry study. J Psychiatry Neurosci (2009) 0.87
Predicting the risk of psychosis onset: advances and prospects. Early Interv Psychiatry (2012) 0.87
Gray matter alterations in schizophrenia high-risk youth and early-onset schizophrenia: a review of structural MRI findings. Child Adolesc Psychiatr Clin N Am (2013) 0.86
Effects of cannabis use on human brain structure in psychosis: a systematic review combining in vivo structural neuroimaging and post mortem studies. Curr Pharm Des (2012) 0.84
Gray matter volumetric abnormalities associated with the onset of psychosis. Front Psychiatry (2012) 0.84
Role of microglial m1/m2 polarization in relapse and remission of psychiatric disorders and diseases. Pharmaceuticals (Basel) (2014) 0.84
Functional outcome in people at high risk for psychosis predicted by thalamic glutamate levels and prefronto-striatal activation. Schizophr Bull (2014) 0.83
Structural alterations of the social brain: a comparison between schizophrenia and autism. PLoS One (2014) 0.82
Approaching a network connectivity-driven classification of the psychosis continuum: a selective review and suggestions for future research. Front Hum Neurosci (2015) 0.82
Genealogy of instruments for prodrome evaluation of psychosis. Front Psychiatry (2013) 0.82
Depressive Symptoms and Brain Metabolite Alterations in Subjects at Ultra-high Risk for Psychosis: A Preliminary Study. Psychiatry Investig (2009) 0.81
Gray matter changes in subjects at high risk for developing psychosis and first-episode schizophrenia: a voxel-based structural MRI study. Front Psychiatry (2013) 0.80
Impaired context processing as a potential marker of psychosis risk state. Psychiatry Res (2013) 0.80
Hippocampal Shape Abnormalities Predict Symptom Progression in Neuroleptic-Free Youth at Ultrahigh Risk for Psychosis. Schizophr Bull (2015) 0.79
Alterations in cortical thickness development in preterm-born individuals: Implications for high-order cognitive functions. Neuroimage (2015) 0.79
Elucidating neuroanatomical alterations in the at risk mental state and first episode psychosis: a combined voxel-based morphometry and voxel-based cortical thickness study. Schizophr Res (2013) 0.77
The polymorphism of YWHAE, a gene encoding 14-3-3epsilon, and brain morphology in schizophrenia: a voxel-based morphometric study. PLoS One (2014) 0.77
Hippocampal volume correlates with attenuated negative psychotic symptoms irrespective of antidepressant medication. Neuroimage Clin (2015) 0.76
Volume and asymmetry abnormalities of insula in antipsychotic-naive schizophrenia: a 3-tesla magnetic resonance imaging study. Indian J Psychol Med (2012) 0.76
Altered Fronto-Temporal Functional Connectivity in Individuals at Ultra-High-Risk of Developing Psychosis. PLoS One (2015) 0.76
Neuroimaging in the field of psychoses. Malays J Med Sci (2011) 0.76
The 2nd Schizophrenia International Research Society Conference, 10-14 April 2010, Florence, Italy: summaries of oral sessions. Schizophr Res (2010) 0.76
Functional Connectivity Anomalies in Adolescents with Psychotic Symptoms. PLoS One (2017) 0.75
Insular pathology in the at-risk mental state. Eur Arch Psychiatry Clin Neurosci (2008) 0.75
Analysis on evolution and research focus in psychiatry field. BMC Psychiatry (2015) 0.75
Understanding pathophysiology is crucial in linking clinical staging to targeted therapeutics. World Psychiatry (2008) 0.75
Abnormalities of localized connectivity in schizophrenia patients and their unaffected relatives: a meta-analysis of resting-state functional magnetic resonance imaging studies. Neuropsychiatr Dis Treat (2017) 0.75
Cerebello-thalamo-cortical networks predict positive symptom progression in individuals at ultra-high risk for psychosis. Neuroimage Clin (2017) 0.75
Abnormal regional homogeneity as potential imaging biomarker for psychosis risk syndrome: a resting-state fMRI study and support vector machine analysis. Sci Rep (2016) 0.75
Identifying Individuals at High Risk of Psychosis: Predictive Utility of Support Vector Machine using Structural and Functional MRI Data. Front Psychiatry (2016) 0.75
Predicting brain metastases for non-small cell lung cancer based on magnetic resonance imaging. Clin Exp Metastasis (2017) 0.75
Reduced Thickness of the Anterior Cingulate Cortex in Individuals With an At-Risk Mental State Who Later Develop Psychosis. Schizophr Bull (2017) 0.75
Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial. Lancet (2008) 6.24
Further Implications of Off-Label Use of Acetazolamide in the Management of Moyamoya Disease in Japan: Response. Radiology (2017) 4.99
Neuroanatomical abnormalities before and after onset of psychosis: a cross-sectional and longitudinal MRI comparison. Lancet (2003) 4.91
Regionally localized thinning of the cerebral cortex in schizophrenia. Arch Gen Psychiatry (2003) 4.84
The psychosis high-risk state: a comprehensive state-of-the-art review. JAMA Psychiatry (2013) 4.16
Elevated striatal dopamine function linked to prodromal signs of schizophrenia. Arch Gen Psychiatry (2009) 3.67
Long-term effect of early treatment with interferon beta-1b after a first clinical event suggestive of multiple sclerosis: 5-year active treatment extension of the phase 3 BENEFIT trial. Lancet Neurol (2009) 3.42
New ischaemic brain lesions on MRI after stenting or endarterectomy for symptomatic carotid stenosis: a substudy of the International Carotid Stenting Study (ICSS). Lancet Neurol (2010) 3.35
Heterogeneity in incidence rates of schizophrenia and other psychotic syndromes: findings from the 3-center AeSOP study. Arch Gen Psychiatry (2006) 3.35
Incidence of schizophrenia and other psychoses in ethnic minority groups: results from the MRC AESOP Study. Psychol Med (2006) 2.79
Cognitive training in Parkinson disease: cognition-specific vs nonspecific computer training. Neurology (2014) 2.74
Antidepressant medications and other treatments of depressive disorders: a CINP Task Force report based on a review of evidence. Int J Neuropsychopharmacol (2007) 2.60
High-potency cannabis and the risk of psychosis. Br J Psychiatry (2009) 2.41
Cognitive functioning in prodromal psychosis: a meta-analysis. Arch Gen Psychiatry (2012) 2.39
The hallucinating brain: a review of structural and functional neuroimaging studies of hallucinations. Neurosci Biobehav Rev (2007) 2.25
Natalizumab treatment for multiple sclerosis: updated recommendations for patient selection and monitoring. Lancet Neurol (2011) 2.19
Diffusion tensor imaging in schizophrenia. Biol Psychiatry (2005) 2.14
Size of burden of schizophrenia and psychotic disorders. Eur Neuropsychopharmacol (2005) 1.96
Reliability and comparability of psychosis patients' retrospective reports of childhood abuse. Schizophr Bull (2009) 1.94
White matter integrity and cognitive impairment in first-episode psychosis. Am J Psychiatry (2010) 1.92
Grey and white matter distribution in very preterm adolescents mediates neurodevelopmental outcome. Brain (2007) 1.91
Association of genetic risks for schizophrenia and bipolar disorder with specific and generic brain structural endophenotypes. Arch Gen Psychiatry (2004) 1.87
Regional volume deviations of brain structure in schizophrenia and psychotic bipolar disorder: computational morphometry study. Br J Psychiatry (2005) 1.83
Tract-specific anisotropy measurements in diffusion tensor imaging. Psychiatry Res (2005) 1.79
Psychotic experiences in the general population: a twenty-year prospective community study. Schizophr Res (2007) 1.77
Presynaptic striatal dopamine dysfunction in people at ultra-high risk for psychosis: findings in a second cohort. Biol Psychiatry (2013) 1.76
Increased pituitary volume in antipsychotic-free and antipsychotic-treated patients of the AEsop first-onset psychosis study. Neuropsychopharmacology (2005) 1.76
Self-harm in first-episode psychosis. Br J Psychiatry (2008) 1.72
Cognitive effects of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: a randomized, open-label clinical trial (EUFEST). Am J Psychiatry (2009) 1.71
Pituitary volume in psychosis. Br J Psychiatry (2004) 1.70
[Do psychiatric patients receive disability pension before adequate diagnostics and treatment? Evaluation of 101 psychiatric expertises done on behalf of Swiss Invalidity Insurance and the Psychiatric Outpatient Department Basel in 2002]. Psychiatr Prax (2005) 1.70
Distinct effects of {delta}9-tetrahydrocannabinol and cannabidiol on neural activation during emotional processing. Arch Gen Psychiatry (2009) 1.69
Parental separation, loss and psychosis in different ethnic groups: a case-control study. Psychol Med (2007) 1.64
Confirmation that the AKT1 (rs2494732) genotype influences the risk of psychosis in cannabis users. Biol Psychiatry (2012) 1.64
Opposite effects of delta-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology. Neuropsychopharmacology (2009) 1.62
The attenuated psychosis syndrome in DSM-5. Schizophr Res (2013) 1.61
Neural systems underlying British Sign Language and audio-visual English processing in native users. Brain (2002) 1.60
Comorbid depressive and anxiety disorders in 509 individuals with an at-risk mental state: impact on psychopathology and transition to psychosis. Schizophr Bull (2012) 1.58
Intervention in individuals at ultra-high risk for psychosis: a review and future directions. J Clin Psychiatry (2009) 1.56
Brain and behaviour in children with 22q11.2 deletion syndrome: a volumetric and voxel-based morphometry MRI study. Brain (2006) 1.54
Cavum septum pellucidum and adhesio interthalamica in schizophrenia: an MRI study. Eur Psychiatry (2006) 1.54
Clinical and social determinants of duration of untreated psychosis in the AESOP first-episode psychosis study. Br J Psychiatry (2006) 1.53
Abnormal frontostriatal interactions in people with prodromal signs of psychosis: a multimodal imaging study. Arch Gen Psychiatry (2010) 1.52
Combined evoked potentials as markers and predictors of disability in early multiple sclerosis. Clin Neurophysiol (2011) 1.51
Glutamate dysfunction in people with prodromal symptoms of psychosis: relationship to gray matter volume. Biol Psychiatry (2009) 1.49
Abnormal cortisol levels during the day and cortisol awakening response in first-episode psychosis: the role of stress and of antipsychotic treatment. Schizophr Res (2009) 1.48
Duration of untreated psychosis and cognitive functioning. Schizophr Res (2013) 1.47
Psychometric properties of the Borderline Symptom List (BSL). Psychopathology (2007) 1.46
Efficacy of using cognitive status in predicting psychosis: a 7-year follow-up. Biol Psychiatry (2009) 1.44
Reductions in frontal, temporal and parietal volume associated with the onset of psychosis. Schizophr Res (2008) 1.43
Radiologic patterns of necrosis after proton therapy of skull base tumors. Can J Neurol Sci (2013) 1.41
First episode psychosis and ethnicity: initial findings from the AESOP study. World Psychiatry (2006) 1.39
Neighbourhood-level effects on psychoses: re-examining the role of context. Psychol Med (2007) 1.38
The structural brain correlates of neurological soft signs in AESOP first-episode psychoses study. Brain (2003) 1.35
Pattern of neural responses to verbal fluency shows diagnostic specificity for schizophrenia and bipolar disorder. BMC Psychiatry (2011) 1.34
A randomized, double-blind, placebo-controlled study of light therapy for antepartum depression. J Clin Psychiatry (2011) 1.32
Different effects of typical and atypical antipsychotics on grey matter in first episode psychosis: the AESOP study. Neuropsychopharmacology (2005) 1.32
Superior temporal lobe dysfunction and frontotemporal dysconnectivity in subjects at risk of psychosis and in first-episode psychosis. Hum Brain Mapp (2009) 1.32
Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report. J Psychopharmacol (2010) 1.31
Molecular imaging studies of the striatal dopaminergic system in psychosis and predictions for the prodromal phase of psychosis. Br J Psychiatry Suppl (2007) 1.31
Gender differences in the association between childhood abuse and psychosis. Br J Psychiatry (2009) 1.30
Association between the neuregulin 1 gene and schizophrenia: a systematic review. Schizophr Bull (2005) 1.30
Regional gray matter abnormalities in obsessive-compulsive disorder: a voxel-based morphometry study. Biol Psychiatry (2005) 1.30
Neuroanatomical abnormalities that predate the onset of psychosis: a multicenter study. Arch Gen Psychiatry (2011) 1.30
Acoustic noise and functional magnetic resonance imaging: current strategies and future prospects. J Magn Reson Imaging (2002) 1.29
Dopamine synthesis capacity in patients with treatment-resistant schizophrenia. Am J Psychiatry (2012) 1.29
Alterations in white matter evident before the onset of psychosis. Schizophr Bull (2012) 1.29
Neural correlates of executive function and working memory in the 'at-risk mental state'. Br J Psychiatry (2009) 1.29
Case management for at-risk elderly patients in the English integrated care pilots: observational study of staff and patient experience and secondary care utilisation. Int J Integr Care (2012) 1.28
The short version of the Borderline Symptom List (BSL-23): development and initial data on psychometric properties. Psychopathology (2008) 1.28
Frontotemporal white matter changes in amyotrophic lateral sclerosis. J Neurol (2005) 1.27
Dissociating linguistic and nonlinguistic gestural communication in the brain. Neuroimage (2004) 1.24
Neural basis of Delta-9-tetrahydrocannabinol and cannabidiol: effects during response inhibition. Biol Psychiatry (2008) 1.24
What causes the onset of psychosis? Schizophr Res (2005) 1.24
Pituitary volume predicts future transition to psychosis in individuals at ultra-high risk of developing psychosis. Biol Psychiatry (2005) 1.24
The dietary pattern of patients with schizophrenia: a systematic review. J Psychiatr Res (2012) 1.23
The very preterm brain in young adulthood: the neural correlates of verbal paired associate learning. J Pediatr (2010) 1.22
An fMRI study of verbal self-monitoring: neural correlates of auditory verbal feedback. Cereb Cortex (2005) 1.22
Specific and generalized neuropsychological deficits: a comparison of patients with various first-episode psychosis presentations. Am J Psychiatry (2009) 1.20
Misattribution of speech and impaired connectivity in patients with auditory verbal hallucinations. Hum Brain Mapp (2007) 1.20
Anterior cingulate glutamate levels related to clinical status following treatment in first-episode schizophrenia. Neuropsychopharmacology (2012) 1.19
Inner speech models of auditory verbal hallucinations: evidence from behavioural and neuroimaging studies. Int Rev Psychiatry (2007) 1.17
Structural brain abnormalities in individuals with an at-risk mental state who later develop psychosis. Br J Psychiatry Suppl (2007) 1.16